87 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
to advance the program after completion of the drug creation phase. There is no assurance, however, that our partners will advance any drug candidates … and quality assurance activities. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may
8-K
EX-99.1
he6t zuk5
21 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
7:31am
8-K
EX-1.1
mmdeo0bkkt3nwcwc6
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-99.1
y9lpplrs665i
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
424B5
mojyz cdlatvwkfe
28 Feb 24
Prospectus supplement for primary offering
8:34am
8-K
6ca3w6bosdz9ry
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
j8z47 c1tyg5phyth
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
0kflhq9
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
EX-99.1
lufrllsiy069wn
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
flgvi3gr
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
EX-99.1
wii347g7cbrnwk q6
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
EX-99.1
hpv88z
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.2
tfxsjakds3rps8v
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm